Full Text View
Tabular View
No Study Results Posted
Related Studies
Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
This study has been completed.
Study NCT00797992   Information provided by Instituto de Olhos de Goiania

First Received on November 24, 2008.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myopic Choroidal Neovascularization
Additional conditions recognized in this trial
Choroidal Neovascularization
Neovascularization, Pathologic
More general conditions related to this trial
Choroid Diseases
Eye Diseases
Metaplasia
Pathologic Processes
Uveal Diseases
Interventions listed in this trial
Injection
Additional drug interventions recognized in this trial
Bevacizumab
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Instituto de Olhos de Goiania


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services